Oncology & Cancer

New model could reduce reliance on chemotherapy

A model co-designed by a professor at Anglia Ruskin University is expected to reduce the need for chemotherapy in up to 38% of breast cancer patients who would previously have been advised to consider the treatment.

Oncology & Cancer

Tool predicts nerve damage from breast cancer treatment

Many women treated for breast cancer using taxanes, a type of cytostatic drug, often experience side effects in the nervous system. Researchers at Linköping University have developed a tool that can predict the risk level ...

Oncology & Cancer

Hormone therapy for breast cancer linked with lower dementia risk

Hormone modulating therapy (HMT) used for the treatment of breast cancer was associated with a 7% lower risk of developing Alzheimer's disease and related dementias later in life, according to a new study published in JAMA ...

page 2 from 4